Comparative Efficacy of Magnesium Supplement and Melatonin Congener in Young Adults With Primary Insomnia
CMH Kharian Medical College
60 participants
May 5, 2025
INTERVENTIONAL
Conditions
Summary
Sleep is essential for our overall health and well-being, much like food and water. It plays a vital role in numerous bodily functions. Many studies have been conducted to determine the efficacy of melatonin congeners and Mg supplements in patients with insomnia separately. This study aims to compare the efficacy of melatonin and magnesium supplements in young adults with primary insomnia. Most insomnia studies focus on older adults or individuals with comorbidities. Targeting otherwise healthy young adults brings age-specific relevance and novel insight.
Eligibility
Inclusion Criteria7
- Age 18-40 years
- Gender: Male and Females (Non-pregnant \& Non lactating)
- Diagnosed cases of primary insomnia according to following criteria:
- Difficulty falling asleep, staying asleep or nonrestorative sleep
- This difficulty is present despite adequate opportunity \& circumstance to sleep
- This impairment in sleep is associated with daytime impairment or distress
- This sleep difficulty occurs at least 3 times per week and has been a problem for at least 1 month
Exclusion Criteria3
- Insomnia due to a known underlying cause
- Any psychiatric illness
- Active use of sedative hypnotics
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Tab Magnesium glycinate 500mg will be given to one group for treatment of primary insomnia
Tab Melatonin 10mg will be given to the other group for treatment of primary insomnia
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06996171